[Clinics in prostate cancer]
- PMID: 15344560
[Clinics in prostate cancer]
Abstract
The prostate gland is characterized by the age-dependent development of abnormal proliferative disease, i.e., benign prostate hyperplasia and prostate cancer. Prostate cancer is the most important disease in our country among the elderly population. The diagnosis and treatment of prostate cancer have been dramatically improved due to the development of PSA screening, transrectal ultrasonography and new anti-androgen drugs, such as LH-RH analog, with fewer side effects. In this article, the pathogenesis, diagnosis and treatment of prostate cancer are summarized.
Similar articles
-
[Neoadjuvant hormonal therapy for prostate cancer].Nihon Rinsho. 2005 Feb;63(2):309-13. Nihon Rinsho. 2005. PMID: 15714984 Japanese.
-
[Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].Arch Esp Urol. 2002 Sep;55(7):771-5. Arch Esp Urol. 2002. PMID: 12380304 Spanish. No abstract available.
-
Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen.Urology. 2005 May;65(5):947-52. doi: 10.1016/j.urology.2004.12.012. Urology. 2005. PMID: 15882729
-
Hormone ablation therapy: lightening the load for today's prostate cancer patient.Urol Nurs. 2007 Feb;27 Suppl:3-11. Urol Nurs. 2007. PMID: 17474637 Review.
-
Endocrine treatment of prostate cancer.J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31. J Steroid Biochem Mol Biol. 2004. PMID: 15663992 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous